The natural course of cystic pancreatic neuroendocrine tumours in MEN1
Pancreatic neuroendocrine tumours (PanNETs) significantly impact life expectancy in multiple endocrine neoplasia type 1 (MEN1). Both solid and cystic pancreatic lesions are observed in MEN1, yet limited research has been focused on cystic lesions in MEN1. While solid PanNETs are generally considered...
Saved in:
Published in | Endocrine oncology Vol. 5; no. 1; p. e240050 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Bioscientifica Ltd
01.01.2025
Bioscientifica |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Pancreatic neuroendocrine tumours (PanNETs) significantly impact life expectancy in multiple endocrine neoplasia type 1 (MEN1). Both solid and cystic pancreatic lesions are observed in MEN1, yet limited research has been focused on cystic lesions in MEN1. While solid PanNETs are generally considered to have an indolent course, the natural course of cystic lesions remains unclear. This study aims to provide more insights into the natural course of cystic PanNETs in MEN1. Patients with MEN1 and radiologically suspected PanNETs, treated at UMC Utrecht and Radboudumc between 2010 and 2023, were included. In the first part, we examined the characteristics of patients with tumours visible on imaging scans. In the second part, we investigated outcomes of pathological examinations, following resection of these lesions. A total of 136 patients were included, comprising 60 men and 76 women. The median follow-up was 5.1 years. [ 68 Ga]Ga-DOTATOC PET/CT scans showed that both cystic and solid lesions demonstrated [ 68 Ga]Ga-DOTATOC PET/CT uptake. The median growth of cystic and solid PanNETs was similar. Pathological examination of 38 resected tumours confirmed that cystic lesions identified on imaging were indeed PanNETs. Cystic lesions had a median diameter of 26 mm at the time of resection, compared to 18 mm for solid lesions, with comparable Ki-67 indices and mitotic counts. We conclude that cystic and solid PanNETs in MEN1 patients appear to be morphological variations of the same entity, suggesting that similar management approaches should be considered. |
---|---|
AbstractList | Pancreatic neuroendocrine tumours (PanNETs) significantly impact life expectancy in multiple endocrine neoplasia type 1 (MEN1). Both solid and cystic pancreatic lesions are observed in MEN1, yet limited research has been focused on cystic lesions in MEN1. While solid PanNETs are generally considered to have an indolent course, the natural course of cystic lesions remains unclear. This study aims to provide more insights into the natural course of cystic PanNETs in MEN1. Patients with MEN1 and radiologically suspected PanNETs, treated at UMC Utrecht and Radboudumc between 2010 and 2023, were included. In the first part, we examined the characteristics of patients with tumours visible on imaging scans. In the second part, we investigated outcomes of pathological examinations, following resection of these lesions. A total of 136 patients were included, comprising 60 men and 76 women. The median follow-up was 5.1 years. [ 68 Ga]Ga-DOTATOC PET/CT scans showed that both cystic and solid lesions demonstrated [ 68 Ga]Ga-DOTATOC PET/CT uptake. The median growth of cystic and solid PanNETs was similar. Pathological examination of 38 resected tumours confirmed that cystic lesions identified on imaging were indeed PanNETs. Cystic lesions had a median diameter of 26 mm at the time of resection, compared to 18 mm for solid lesions, with comparable Ki-67 indices and mitotic counts. We conclude that cystic and solid PanNETs in MEN1 patients appear to be morphological variations of the same entity, suggesting that similar management approaches should be considered. Pancreatic neuroendocrine tumours (PanNETs) significantly impact life expectancy in multiple endocrine neoplasia type 1 (MEN1). Both solid and cystic pancreatic lesions are observed in MEN1, yet limited research has been focused on cystic lesions in MEN1. While solid PanNETs are generally considered to have an indolent course, the natural course of cystic lesions remains unclear. This study aims to provide more insights into the natural course of cystic PanNETs in MEN1. Patients with MEN1 and radiologically suspected PanNETs, treated at UMC Utrecht and Radboudumc between 2010 and 2023, were included. In the first part, we examined the characteristics of patients with tumours visible on imaging scans. In the second part, we investigated outcomes of pathological examinations, following resection of these lesions. A total of 136 patients were included, comprising 60 men and 76 women. The median follow-up was 5.1 years. [68Ga]Ga-DOTATOC PET/CT scans showed that both cystic and solid lesions demonstrated [68Ga]Ga-DOTATOC PET/CT uptake. The median growth of cystic and solid PanNETs was similar. Pathological examination of 38 resected tumours confirmed that cystic lesions identified on imaging were indeed PanNETs. Cystic lesions had a median diameter of 26 mm at the time of resection, compared to 18 mm for solid lesions, with comparable Ki-67 indices and mitotic counts. We conclude that cystic and solid PanNETs in MEN1 patients appear to be morphological variations of the same entity, suggesting that similar management approaches should be considered.Pancreatic neuroendocrine tumours (PanNETs) significantly impact life expectancy in multiple endocrine neoplasia type 1 (MEN1). Both solid and cystic pancreatic lesions are observed in MEN1, yet limited research has been focused on cystic lesions in MEN1. While solid PanNETs are generally considered to have an indolent course, the natural course of cystic lesions remains unclear. This study aims to provide more insights into the natural course of cystic PanNETs in MEN1. Patients with MEN1 and radiologically suspected PanNETs, treated at UMC Utrecht and Radboudumc between 2010 and 2023, were included. In the first part, we examined the characteristics of patients with tumours visible on imaging scans. In the second part, we investigated outcomes of pathological examinations, following resection of these lesions. A total of 136 patients were included, comprising 60 men and 76 women. The median follow-up was 5.1 years. [68Ga]Ga-DOTATOC PET/CT scans showed that both cystic and solid lesions demonstrated [68Ga]Ga-DOTATOC PET/CT uptake. The median growth of cystic and solid PanNETs was similar. Pathological examination of 38 resected tumours confirmed that cystic lesions identified on imaging were indeed PanNETs. Cystic lesions had a median diameter of 26 mm at the time of resection, compared to 18 mm for solid lesions, with comparable Ki-67 indices and mitotic counts. We conclude that cystic and solid PanNETs in MEN1 patients appear to be morphological variations of the same entity, suggesting that similar management approaches should be considered. Pancreatic neuroendocrine tumours (PanNETs) significantly impact life expectancy in multiple endocrine neoplasia type 1 (MEN1). Both solid and cystic pancreatic lesions are observed in MEN1, yet limited research has been focused on cystic lesions in MEN1. While solid PanNETs are generally considered to have an indolent course, the natural course of cystic lesions remains unclear. This study aims to provide more insights into the natural course of cystic PanNETs in MEN1. Patients with MEN1 and radiologically suspected PanNETs, treated at UMC Utrecht and Radboudumc between 2010 and 2023, were included. In the first part, we examined the characteristics of patients with tumours visible on imaging scans. In the second part, we investigated outcomes of pathological examinations, following resection of these lesions. A total of 136 patients were included, comprising 60 men and 76 women. The median follow-up was 5.1 years. [ Ga]Ga-DOTATOC PET/CT scans showed that both cystic and solid lesions demonstrated [ Ga]Ga-DOTATOC PET/CT uptake. The median growth of cystic and solid PanNETs was similar. Pathological examination of 38 resected tumours confirmed that cystic lesions identified on imaging were indeed PanNETs. Cystic lesions had a median diameter of 26 mm at the time of resection, compared to 18 mm for solid lesions, with comparable Ki-67 indices and mitotic counts. We conclude that cystic and solid PanNETs in MEN1 patients appear to be morphological variations of the same entity, suggesting that similar management approaches should be considered. Pancreatic neuroendocrine tumours (PanNETs) significantly impact life expectancy in multiple endocrine neoplasia type 1 (MEN1). Both solid and cystic pancreatic lesions are observed in MEN1, yet limited research has been focused on cystic lesions in MEN1. While solid PanNETs are generally considered to have an indolent course, the natural course of cystic lesions remains unclear. This study aims to provide more insights into the natural course of cystic PanNETs in MEN1. Patients with MEN1 and radiologically suspected PanNETs, treated at UMC Utrecht and Radboudumc between 2010 and 2023, were included. In the first part, we examined the characteristics of patients with tumours visible on imaging scans. In the second part, we investigated outcomes of pathological examinations, following resection of these lesions. A total of 136 patients were included, comprising 60 men and 76 women. The median follow-up was 5.1 years. [ 68 Ga]Ga-DOTATOC PET/CT scans showed that both cystic and solid lesions demonstrated [ 68 Ga]Ga-DOTATOC PET/CT uptake. The median growth of cystic and solid PanNETs was similar. Pathological examination of 38 resected tumours confirmed that cystic lesions identified on imaging were indeed PanNETs. Cystic lesions had a median diameter of 26 mm at the time of resection, compared to 18 mm for solid lesions, with comparable Ki-67 indices and mitotic counts. We conclude that cystic and solid PanNETs in MEN1 patients appear to be morphological variations of the same entity, suggesting that similar management approaches should be considered. Pancreatic neuroendocrine tumours (PanNETs) significantly impact life expectancy in multiple endocrine neoplasia type 1 (MEN1). Both solid and cystic pancreatic lesions are observed in MEN1, yet limited research has been focused on cystic lesions in MEN1. While solid PanNETs are generally considered to have an indolent course, the natural course of cystic lesions remains unclear. This study aims to provide more insights into the natural course of cystic PanNETs in MEN1. Patients with MEN1 and radiologically suspected PanNETs, treated at UMC Utrecht and Radboudumc between 2010 and 2023, were included. In the first part, we examined the characteristics of patients with tumours visible on imaging scans. In the second part, we investigated outcomes of pathological examinations, following resection of these lesions. A total of 136 patients were included, comprising 60 men and 76 women. The median follow-up was 5.1 years. [68Ga]Ga-DOTATOC PET/CT scans showed that both cystic and solid lesions demonstrated [68Ga]Ga-DOTATOC PET/CT uptake. The median growth of cystic and solid PanNETs was similar. Pathological examination of 38 resected tumours confirmed that cystic lesions identified on imaging were indeed PanNETs. Cystic lesions had a median diameter of 26 mm at the time of resection, compared to 18 mm for solid lesions, with comparable Ki-67 indices and mitotic counts. We conclude that cystic and solid PanNETs in MEN1 patients appear to be morphological variations of the same entity, suggesting that similar management approaches should be considered. |
Author | de Laat, Joanne M Pieterman, Carolina R C Braat, Arthur J A T Valk, Gerlof D van de Ven, Annenienke C van Vliembergen, Eline N M |
AuthorAffiliation | 3 Department of Radiology and Nuclear Medicine, University Medical Centre Utrecht , Utrecht , The Netherlands 2 Department of Endocrinology, Radboud University Medical Centre , Nijmegen , The Netherlands 1 Department of Endocrine Oncology, University Medical Centre Utrecht , Utrecht , The Netherlands |
AuthorAffiliation_xml | – name: 2 Department of Endocrinology, Radboud University Medical Centre , Nijmegen , The Netherlands – name: 1 Department of Endocrine Oncology, University Medical Centre Utrecht , Utrecht , The Netherlands – name: 3 Department of Radiology and Nuclear Medicine, University Medical Centre Utrecht , Utrecht , The Netherlands |
Author_xml | – sequence: 1 givenname: Eline N M orcidid: 0009-0008-9872-5937 surname: van Vliembergen fullname: van Vliembergen, Eline N M organization: Department of Endocrine Oncology, University Medical Centre Utrecht, Utrecht, The Netherlands, Department of Endocrinology, Radboud University Medical Centre, Nijmegen, The Netherlands – sequence: 2 givenname: Carolina R C surname: Pieterman fullname: Pieterman, Carolina R C organization: Department of Endocrine Oncology, University Medical Centre Utrecht, Utrecht, The Netherlands – sequence: 3 givenname: Annenienke C surname: van de Ven fullname: van de Ven, Annenienke C organization: Department of Endocrinology, Radboud University Medical Centre, Nijmegen, The Netherlands – sequence: 4 givenname: Arthur J A T surname: Braat fullname: Braat, Arthur J A T organization: Department of Radiology and Nuclear Medicine, University Medical Centre Utrecht, Utrecht, The Netherlands – sequence: 5 givenname: Gerlof D surname: Valk fullname: Valk, Gerlof D organization: Department of Endocrine Oncology, University Medical Centre Utrecht, Utrecht, The Netherlands – sequence: 6 givenname: Joanne M surname: de Laat fullname: de Laat, Joanne M organization: Department of Endocrine Oncology, University Medical Centre Utrecht, Utrecht, The Netherlands, Department of Endocrinology, Radboud University Medical Centre, Nijmegen, The Netherlands |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/39949334$$D View this record in MEDLINE/PubMed |
BookMark | eNpVkU1P3DAQhi1EBRS48ANQjggprb8_ThVaLS0S7V7o2XLsMQRl7a2dIPHvyXYBwckjz6NnRvN-RfspJ0DojOBvRDD8fblqKW8xFngPHVHJeMuVYfsf6kN0WusjxphqRbWUB-iQGcMNY_wIXd89QJPcOBU3ND5PpUKTY-Of69j7ZuOSL-C2ZYKpZEgh-9InaMZpvYWbPjW_l3_ICfoS3VDh9PU9Rn-vl3eLX-3t6ufN4uq29ZQb3GqqvAkiOq5pEEwFHLEBTIOUXVDeGaM0F4QrRTsmTdSsIzgEhyWJPDrMjtHNzhuye7Sb0q9debbZ9fb_Ry731pV53QGsjrOCdEAFjVxxrbnj3DFFoqS402x2_di5NlO3huAhjfMRPkk_d1L_YO_zkyVEU0Gkng0Xr4aS_01QR7vuq4dhcAnyVC0jUiopBRUzev5x2PuUtyRm4HIH-JJrLRDfEYLtNmm7XFnK7TZp9gKq4JjM |
ContentType | Journal Article |
Copyright | the author(s). the author(s) 2025 the author(s) |
Copyright_xml | – notice: the author(s). – notice: the author(s) 2025 the author(s) |
DBID | AAYXX CITATION NPM 7X8 5PM DOA |
DOI | 10.1530/EO-24-0050 |
DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | CrossRef MEDLINE - Academic PubMed |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 2634-4793 |
ExternalDocumentID | oai_doaj_org_article_8fb361be252f474884a44a371f620b83 PMC11825168 39949334 10_1530_EO_24_0050 |
Genre | Journal Article |
GrantInformation_xml | – fundername: ; grantid: 13575 |
GroupedDBID | 53G AAFZV AAKMT AAYXX ALMA_UNASSIGNED_HOLDINGS CITATION EBS GROUPED_DOAJ M~E PGMZT RPM TBS NPM 7X8 5PM |
ID | FETCH-LOGICAL-c2490-827c9d5fa482d537d0f09e02d66bd7ca99784514772b369f83b10dda061f4fa03 |
IEDL.DBID | DOA |
ISSN | 2634-4793 |
IngestDate | Wed Aug 27 01:25:06 EDT 2025 Thu Aug 21 18:29:19 EDT 2025 Fri Jul 11 04:47:24 EDT 2025 Sun Feb 16 01:21:12 EST 2025 Wed Sep 03 16:33:53 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | natural course histopathology multiple endocrine neoplasia type 1 pancreatic neuroendocrine tumour cystic |
Language | English |
License | the author(s). This work is licensed under a Creative Commons Attribution 4.0 International License. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c2490-827c9d5fa482d537d0f09e02d66bd7ca99784514772b369f83b10dda061f4fa03 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0009-0008-9872-5937 0000-0003-3316-1540 |
OpenAccessLink | https://doaj.org/article/8fb361be252f474884a44a371f620b83 |
PMID | 39949334 |
PQID | 3166766525 |
PQPubID | 23479 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_8fb361be252f474884a44a371f620b83 pubmedcentral_primary_oai_pubmedcentral_nih_gov_11825168 proquest_miscellaneous_3166766525 pubmed_primary_39949334 crossref_primary_10_1530_EO_24_0050 |
PublicationCentury | 2000 |
PublicationDate | 2025-Jan |
PublicationDateYYYYMMDD | 2025-01-01 |
PublicationDate_xml | – month: 01 year: 2025 text: 2025-Jan |
PublicationDecade | 2020 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: Bristol |
PublicationTitle | Endocrine oncology |
PublicationTitleAlternate | Endocr Oncol |
PublicationYear | 2025 |
Publisher | Bioscientifica Ltd Bioscientifica |
Publisher_xml | – name: Bioscientifica Ltd – name: Bioscientifica |
References | Thakker RV (bib12) 2012; 97 Khoury T (bib7) 2024; 36 Bordeianou L (bib2) 2008; 206 Niederle B (bib8) 2021; 111 Virgolini I (bib16) 2016; 43 van Beek DJ (bib14) 2023; 32 de Laat JM (bib3) 2013; 98 Sakurai A (bib9) 2012; 76 van Beek DJ (bib13) 2018; 7 Takeshita K (bib11) 1994; 19 de Laat JM (bib4) 2016; 14 Goudet P (bib6) 2011; 165 Singhi AD (bib10) 2012; 36 Zhu JK (bib17) 2019; 19 Goudet P (bib5) 2010; 34 Ahrendt SA (bib1) 2002; 6 van Vliembergen ENM (bib15) 2023; 14 |
References_xml | – volume: 7 start-page: R260 year: 2018 ident: bib13 article-title: ‘Quality in, quality out’, a stepwise approach to evidence-based medicine for rare diseases promoted by multiple endocrine neoplasia type 1 – volume: 76 start-page: 533 year: 2012 ident: bib9 article-title: Multiple endocrine neoplasia type 1 in Japan: establishment and analysis of a multicentre database – volume: 97 start-page: 2990 year: 2012 ident: bib12 article-title: Clinical practice guidelines for multiple endocrine neoplasia type 1 (MEN1) – volume: 14 start-page: 182 year: 2016 ident: bib4 article-title: MEN1 redefined, a clinical comparison of mutation-positive and mutation-negative patients – volume: 19 start-page: 225 year: 1994 ident: bib11 article-title: Cystic islet cell tumors: radiologic findings in three cases – volume: 19 start-page: 738 year: 2019 ident: bib17 article-title: Cystic pancreatic neuroendocrine tumors: a distinctive subgroup with indolent biological behavior? A systematic review and meta-analysis – volume: 206 start-page: 1154 year: 2008 ident: bib2 article-title: Cystic pancreatic endocrine neoplasms: a distinct tumor type? – volume: 98 start-page: 4143 year: 2013 ident: bib3 article-title: Low accuracy of tumor markers for diagnosing pancreatic neuroendocrine tumors in multiple endocrine neoplasia type 1 patients – volume: 34 start-page: 249 year: 2010 ident: bib5 article-title: Risk factors and causes of death in MEN1 disease. A GTE (Groupe d'Etude des Tumeurs Endocrines) cohort study among 758 patients – volume: 36 start-page: 395 year: 2024 ident: bib7 article-title: Safety and efficacy of endoscopic ultrasound-guided radiofrequency ablation for pancreatic neuroendocrine neoplasms: systematic review and meta-analysis – volume: 14 year: 2023 ident: bib15 article-title: Precision radiotherapy using MR-linac for pancreatic neuroendocrine tumors in MEN1 patients (PRIME): a protocol for a phase I-II trial, and systematic review on available evidence for radiotherapy of pNETs – volume: 165 start-page: 97 year: 2011 ident: bib6 article-title: Gender-related differences in MEN1 lesion occurrence and diagnosis: a cohort study of 734 cases from the Groupe d'etude des Tumeurs Endocrines – volume: 36 start-page: 1666 year: 2012 ident: bib10 article-title: Cystic pancreatic neuroendocrine tumors: a clinicopathologic study – volume: 43 start-page: 2072 year: 2016 ident: bib16 article-title: Current knowledge on the sensitivity of the (68)Ga-somatostatin receptor positron emission tomography and the SUVmax reference range for management of pancreatic neuroendocrine tumours – volume: 6 start-page: 66 year: 2002 ident: bib1 article-title: Cystic pancreatic neuroendocrine tumors: is preoperative diagnosis possible? – volume: 111 start-page: 609 year: 2021 ident: bib8 article-title: Multiple endocrine neoplasia type 1 and the pancreas: diagnosis and treatment of functioning and non-functioning pancreatic and duodenal neuroendocrine neoplasia within the MEN1 syndrome–an international consensus statement – volume: 32 start-page: 343 year: 2023 ident: bib14 article-title: Status of surveillance and nonsurgical therapy for small nonfunctioning pancreatic neuroendocrine tumors |
SSID | ssj0002872866 |
Score | 2.2789683 |
Snippet | Pancreatic neuroendocrine tumours (PanNETs) significantly impact life expectancy in multiple endocrine neoplasia type 1 (MEN1). Both solid and cystic... |
SourceID | doaj pubmedcentral proquest pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database |
StartPage | e240050 |
SubjectTerms | cystic histopathology multiple endocrine neoplasia type 1 natural course pancreatic neuroendocrine tumour |
Title | The natural course of cystic pancreatic neuroendocrine tumours in MEN1 |
URI | https://www.ncbi.nlm.nih.gov/pubmed/39949334 https://www.proquest.com/docview/3166766525 https://pubmed.ncbi.nlm.nih.gov/PMC11825168 https://doaj.org/article/8fb361be252f474884a44a371f620b83 |
Volume | 5 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1NT9wwELUQB8QFFWhp-JKr9hoRf8Y5AtoVQlr2UiRuluMPFaQmVbt74N8z44TVboXEhWtiKda8seY9Z_xMyI-aSeUTqBNnYlXKoJrScTyxDAnDHFSIEFAozu70zb28fVAPa1d9YU_YYA88BO7CpFZo1kaueJI1pJt0UjpRs6R51Zrs8wk1b01MPeUto5obrUc_UiWqi8m85LJEu5ONCpSN-t9il_83Sa5VneknsjfSRXo5THOfbMXugOzMxh_ih2QKMNNszgmjfI8dGbRP1D-j_TKFlT6QQk-zb2XsQu_xuB9dLH_jYPrY0dnkjn0m99PJz-ubcrwaofSgl_Dwd-2boJKThgcl6lClqokVD1q3ofauAXEogQsBd4bwNcmIllUhOKjeSSZXiS9ku-u7-JXQKJTgbQoKVqOMiRntYg2rXjTOC6l4Qb6_hsv-GRwwLCoHCKqdzC2XFoNakCuM5GoEulbnB4ClHbG072FZkG-vOFjIcvx14brYL_9ZwbAXVyuuCnI04LL6FFAs2QghC2I2ENuYy-ab7vFXdtJGdaWYNscfMfsTssvxcuC8P3NKthd_l_EMGMuiPc_JeZ63kl4AG5TnhQ |
linkProvider | Directory of Open Access Journals |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+natural+course+of+cystic+pancreatic+neuroendocrine+tumours+in+MEN1&rft.jtitle=Endocrine+oncology&rft.au=van+Vliembergen%2C+Eline+N+M&rft.au=Pieterman%2C+Carolina+R+C&rft.au=van+de+Ven%2C+Annenienke+C&rft.au=Braat%2C+Arthur+J+A+T&rft.date=2025-01-01&rft.issn=2634-4793&rft.eissn=2634-4793&rft.volume=5&rft.issue=1&rft.spage=e240050&rft_id=info:doi/10.1530%2FEO-24-0050&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2634-4793&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2634-4793&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2634-4793&client=summon |